Reactivation of latent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection is a dreaded complication in the immunocompromised host. In this doctoral thesis, the role of CMV and EBV reactivation in immunocompromised patients with therapy-refractory chronic skin diseases was investigated. The results support the hypothesis that inflammation and immunosuppression predispose to reactivation of CMV and EBV infection and that CMV (EBV) reactivation, in turn, hinders the efficacy of immunomodulating/immunosuppressive treatment and even worsens the skin pathology.
«
Reactivation of latent cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection is a dreaded complication in the immunocompromised host. In this doctoral thesis, the role of CMV and EBV reactivation in immunocompromised patients with therapy-refractory chronic skin diseases was investigated. The results support the hypothesis that inflammation and immunosuppression predispose to reactivation of CMV and EBV infection and that CMV (EBV) reactivation, in turn, hinders the efficacy of immunomodu...
»